Lemonade Inc.

Lemonade reported accelerated premium growth at the Oppenheimer conference (booked gross premiums +33% y/y) with declining claims handling costs (5% vs. industry ~9%) and strong auto growth (+60% y/y). Management is targeting positive EBITDA for Q4 2024 and full-year 2025 and expects a positive net income in the medium term after sustained positive EBITDA. AI and automation are speeding product launches and approvals but, according to management, are still in early stages of use. Capital returns, share buybacks and M&A are not short-term priorities; growth remains the priority, with a target growth rate of 30–45% p.a. as long as capital buffers remain sufficient. » More on de.investing.com

Lemonade is scaling insurance sales using AI-driven quoting and claims automation, reporting 3.3 million policyholders and $1.4 billion in-force premium as of June 30. In Q2 revenue rose 79% year-over-year to $294.4 million, gross loss ratio fell to a record 60% and loss adjustment expense hit 5%, while management raised 2026 revenue guidance to about $1.217 billion. With a trailing P/S of 4.2, management believes growing IFP to $10 billion by 2034 could multiply shareholder returns, though sustaining current loss and expense ratios presents execution risk. » More on finance.yahoo.com

Lemonade shares fell 8.2% premarket to $57 after Q2 2026 results missed high expectations. Analyst expectations for losses and about 77% revenue growth were not met, weighing on sentiment amid earlier downgrades and net insider sell-offs. Despite an improved gross loss ratio and an upgraded full-year outlook with a positive adjusted EBITDA expectation for Q4, the valuation remains under pressure and the stock is far below its 52-week high. » More on de.investing.com